You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 6, 2025

Drug Price Trends for NDC 68180-0891


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 68180-0891

Drug Name NDC Price/Unit ($) Unit Date
ENSKYCE 28 TABLET 68180-0891-71 0.12171 EACH 2024-04-17
ENSKYCE 28 TABLET 68180-0891-73 0.12171 EACH 2024-04-17
ENSKYCE 28 TABLET 68180-0891-71 0.15908 EACH 2024-03-20
ENSKYCE 28 TABLET 68180-0891-73 0.15908 EACH 2024-03-20
ENSKYCE 28 TABLET 68180-0891-71 0.16287 EACH 2024-02-21
ENSKYCE 28 TABLET 68180-0891-73 0.16287 EACH 2024-02-21
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 68180-0891

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for the Drug NDC: 68180-0891

Introduction

The pharmaceutical industry is a complex and dynamic market, influenced by a multitude of factors including regulatory changes, technological advancements, and economic conditions. This article will focus on the market analysis and price projections for the drug identified by the NDC code 68180-0891, although specific details for this NDC are not provided in the sources. We will use general trends and insights from the pharmaceutical industry to infer potential market dynamics.

Drug Identification and Description

To begin with, it is crucial to identify the drug associated with the NDC code 68180-0891. However, since the specific drug details are not available in the provided sources, we will assume it is a prescription medication, possibly a combination drug like DROSP-EE-LEVOMEF (a combination of drospirenone and ethinyl estradiol), which is similar to other drugs listed under the same NDC prefix.

Market Trends in the Pharmaceutical Industry

The pharmaceutical industry is undergoing significant transformations driven by several key trends:

Prevention and Personalization

There is a growing focus on prevention and personalization in healthcare. This involves addressing risk factors for health decline and using data-driven, customized treatments based on genetics and behavior. Such trends can influence the demand and pricing of specific drugs as they become more targeted and effective[3].

Technological Advancements

The adoption of AI-based tools in drug discovery is a significant trend. AI can accelerate the development process, reduce costs, and improve the efficacy of drugs. This could lead to more innovative and cost-effective treatments, potentially impacting the pricing and market dynamics of existing drugs[4].

Regulatory and Policy Changes

Regulatory and policy changes can significantly impact the pharmaceutical market. Changes in government policies, tariffs, taxes, and M&A oversight can accelerate or hinder the growth of pharmaceutical companies. For instance, the policy positions of new administrations can influence health policies and the overall business model of pharmaceutical companies[3].

Price Projections and Market Analysis

Historical Price Trends

For drugs with available data, historical price trends can provide insights into future price projections. For example, the prices of drugs like DROSP-EE-LEVOMEF have shown fluctuations over time, influenced by factors such as production costs, market demand, and regulatory changes. If the drug associated with NDC 68180-0891 follows similar patterns, its price could be subject to similar fluctuations[1].

Market Demand and Supply

The demand for a drug is a critical factor in determining its price. Increasing workplace-associated disorders and an aging population can drive up demand for certain medications, potentially leading to higher prices. On the other hand, greater approvals of generic drugs can increase competition and drive prices down[4].

Production Costs and R&D Investments

High costs associated with drug development and marketing approval can hinder the growth of the pharmaceutical market but also justify higher prices for innovative drugs. Increasing R&D investments, however, can lead to more efficient production processes and potentially lower costs in the long run[4].

Economic and Financial Outlook

Market Size and Growth

The US pharmaceutical market is projected to grow significantly, from $846.72 billion in 2022 to $1.28 trillion by 2030, representing a CAGR of 5.36%. This growth is driven by various factors including rising demand, increased pharmaceutical production capacity, and greater approvals of generic drugs[4].

Investor Sentiment

Investors are cautious about the long-term sustainability of traditional pharmaceutical business models. The decline in the enterprise-value-to-EBITDA multiple for pharmaceutical companies since 2018 indicates a shift in investor sentiment, reflecting concerns about the industry's ability to adapt to emerging trends[3].

Competitive Landscape

Generic Drugs and Biosimilars

The increasing approval and adoption of generic drugs and biosimilars can significantly impact the pricing of branded drugs. As more generic alternatives become available, the market share and prices of branded drugs may decline[4].

Innovative Treatments

The development of innovative treatments, especially those leveraging AI and personalized medicine, can create new market opportunities but also increase competition. Companies that invest in these areas may see higher prices for their innovative products due to their unique value proposition[3].

Regulatory Considerations

Recalls and Safety Alerts

Regulatory actions such as drug recalls can impact the market and pricing of affected drugs. For instance, recalls due to safety concerns can lead to a temporary reduction in supply, potentially affecting prices[5].

Approval Processes

The efficiency and speed of drug approval processes can influence the market entry and pricing of new drugs. Streamlined approval processes can lead to faster market entry, which may affect the pricing dynamics of existing drugs[4].

Conclusion

The market analysis and price projections for the drug associated with NDC 68180-0891 depend on various factors including market trends, regulatory changes, technological advancements, and economic conditions. Here are some key takeaways:

  • Technological Advancements: AI and personalized medicine are driving innovation and potentially affecting drug prices.
  • Regulatory Changes: Policy and regulatory shifts can significantly impact the pharmaceutical market.
  • Market Demand: Increasing demand due to health trends and an aging population can drive prices up.
  • Competition: Generic drugs and biosimilars can reduce prices for branded drugs.
  • Economic Outlook: The US pharmaceutical market is projected to grow significantly, but investor sentiment remains cautious.

Key Takeaways

  • The pharmaceutical industry is evolving with a focus on prevention, personalization, and technological advancements.
  • Regulatory and policy changes are crucial in shaping the market.
  • Market demand and supply dynamics, along with competition from generic drugs, influence prices.
  • The overall economic outlook is positive but cautious due to changing investor sentiment.

FAQs

Q: What are the key trends shaping the future of the pharmaceutical industry? A: The key trends include a focus on prevention, personalization, prediction, and point of care, along with the adoption of AI-based tools for drug discovery[3].

Q: How does the adoption of AI impact drug development and pricing? A: AI can accelerate drug development, reduce costs, and improve efficacy, potentially leading to more cost-effective treatments and influencing pricing dynamics[4].

Q: What is the projected growth of the US pharmaceutical market? A: The US pharmaceutical market is projected to grow from $846.72 billion in 2022 to $1.28 trillion by 2030, representing a CAGR of 5.36%[4].

Q: How do regulatory changes affect the pharmaceutical market? A: Regulatory changes can impact drug approval processes, recalls, and overall market dynamics, influencing the pricing and availability of drugs[3][5].

Q: What role do generic drugs and biosimilars play in the pharmaceutical market? A: Generic drugs and biosimilars increase competition, potentially reducing the prices of branded drugs and affecting market share[4].

Sources

  1. DrugPatentWatch - Latest drug prices and trends for NDC 68180-0894.
  2. DrugPatentWatch - Latest drug prices and trends for NDC 68180-0214.
  3. PwC - Pharma industry trends: Meeting the moment.
  4. GlobeNewswire - US Pharmaceutical Market Review 2020-2023 and Forecast.
  5. California State Board of Pharmacy - Recall notice for Lupin Pharmaceuticals Inc.

More… ↓

⤷  Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.